HopeStage
Back to all studies
CompletedNCT05701345

Virtual reality-based medical device study for depression

About this titleRead the official source — NCT05701345
Device studyAges 19–64South Korea
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 64 years.

Listed locations
Ilsan and 4 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 9, 2023
Recruitment status
Completed
Enrollment listed in the registry
162
Sponsor
Omni C&S
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device, Other
Locations
South Korea
Age range
From 19 Years to 64 Years
Official registry ID
NCT05701345
Official title
Show the full official title

Prospective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ilsan · Jeju City · Seoul

1 more locations
  • Suwon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Omni C&S.

Who was this study for?

Listed age limits: 19 years to 64 years.

Want to explore more studies?

Explore studies